The Urologic Impact of Guillain–Barré Syndrome
- 174 Downloads
Guillain–Barré Syndrome is an acute flaccid paralysis that is rapidly progressing. Neurologic decline continues for 12 hours to 4 weeks after symptom onset. Approximately 25% of patients develop acute urinary symptoms such as difficulty voiding or frank urinary retention. Longer term urinary symptoms include persistent overactive bladder and nocturia. Key urologic interventions include indwelling catheter during acute phase, particularly when patient is experiencing respiratory failure; intermittent catheterization for retention if patient has preserved hand function; voiding trial after neurologic recovery; and anticholinergics for persistent overactive bladder after recovery.
KeywordsNeurourology Urodynamic studies Guillain–Barré Urinary retention Nocturia
- 1.Guillain G. Radiculoneuritis with acellular hyperalbuminosis of the cerebrospinal fluid. Arch Neurol Psychiatr. 1936:975–90.Google Scholar
- 20.van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group N Engl J Med. 1992;326:1123–9.Google Scholar
- 26.Amatya, B., Khan, F., Whishaw, M. & Pallant, J. F. Guillain-Barre syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort.[Erratum appears in J Clin Neurol. 2013;9(4):289–90]. J Clin Neurol. 2013;9:144–50.Google Scholar